Erika Carmel-tech Ltd. (ERKA.TA)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in ILS| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ILS m | 86 | 97 | 50 | 30 | 38 | 37 | 37 | - |
| Operating profit | ILS m | -4 | -4 | ||||||
| Net profit | ILS m | 12 | -22 | -33 | -19 | -9 | -6 | -6 | - |
| EPS reported | ILS | -0.14 | -0.13 | ||||||
| Operating cashflow per share | ILS | 0.03 | 0.03 | ||||||
| Capex per share | ILS | 0.00 | 0.00 | ||||||
| FCF per share | ILS | 0.03 | 0.03 | ||||||
| Free cash flow | ILS m | 1 | 1 | ||||||
| Net debt | ILS m | -4 | -4 | ||||||
| Book value equity | ILS m | 10 | 10 | ||||||
| Book value per share | ILS | 0.23 | 0.23 | ||||||
| Number of shares | m | 41.67 | 41.67 | ||||||
| DPS (TTM paid) | ILS | 0.00 | 0.00 |
Financial summary
Financials in ILS| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 2.02 | 2.02 | ||||||
| P/S LTM | x | 0.53 | 0.53 | ||||||
| P/FCF LTM | x | 14.76 | 14.76 | ||||||
| EV/EBITDA LTM | x | -6.57 | -6.30 | ||||||
| EV/Sales LTM | x | 0.49 | 0.51 | ||||||
| Earnings Yield LTM | % | -29.57% | -28.90% | ||||||
| FCF Yield | % | +6.78% | +6.78% | ||||||
| Quality | |||||||||
| ROE | % | -59.80% | -50.48% | ||||||
| ROIC | % | -31.97% | -33.03% | ||||||
| Operating margin | % | -11.83% | -11.83% | ||||||
| Gross margin | % | +65.14% | +69.29% | ||||||
| FCF/Sales | % | +3.59% | +3.59% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -1.64% | -1.64% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.53 | 0.53 | ||||||
| Net Debt/EBITDA | x | 0.48 | 0.46 | ||||||
| EBIT/Net interest | x | -3.53 | -3.53 | ||||||
| Net debt/market cap | % | 0.00% | 0.00% | ||||||
| Net debt/Equity | x | -0.42 | -0.42 | ||||||
| Gross debt/equity | x | 0.26 | 0.26 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Erika Carmel-Tech Ltd. is an international company, which develops markets and distributes the B-Cure Laser products. It is designed to treat pain, orthopedic disorders, wounds and inflammations, for daily domestic use in the comfort of home; these are a series of revolutionary lightweight and portable devices. The company was founded on October 9, 2007 and is headquartered in Haifa, Israel.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Erika Carmel-Tech Ltd. is an international company, which develops markets and distributes the B-Cure Laser products. It is designed to treat pain, orthopedic disorders, wounds and inflammations, for daily domestic use in the comfort of home; these are a series of revolutionary lightweight and portable devices. The company was founded on October 9, 2007 and is headquartered in Haifa, Israel.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free